Astellas Pharma, Inc.

{
  "main_header": {
    "sid": 1130126,
    "name": "Astellas Pharma, Inc.",
    "stock_name": "Astellas Pharma, Inc.",
    "full_name": "Astellas Pharma, Inc.",
    "name_url": "stocks-analysis/astellas-pharma-inc",
    "exchange": 121,
    "exchangecode": "TKS",
    "country_id": 23,
    "currency": "JPY",
    "cmp": "2,441.00",
    "chg": 20,
    "chgp": "0.83%",
    "dir": 1,
    "prev_price": "2,421.00",
    "mcapval": "4,060,883.94",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "Japan Nikkei 225",
    "isin": "JP3942400007",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "21.03 M",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astellas-pharma-inc-1130126-121&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Astellas Pharma, Inc. Shows Strong Financial Growth Amidst Flat Performance",
        "link": "https://www.marketsmojo.com/news/mojo-premium/astellas-pharma-inc-enters-mojo-stocks-strategy-with-strong-financials-3690068",
        "imagepath": "",
        "date": "2025-11-11 16:16:05",
        "description": "<p><strong>Astellas Pharma, Inc.</strong> has reported its financial results for the quarter ending June 2025, revealing a mixed performance characterized by notable growth in key profit metrics despite an overall flat financial performance. The company's operating profit reached an impressive JPY 157,307 MM, marking the highest level recorded, with an operating profit margin of 31.1%. This indicates a strong operational efficiency and profitability for the company during this period.</p>\n\n<p>In addition to the robust operating profit, <strong>Astellas Pharma, Inc.</strong> also reported significant growth in its pre-tax profit, which surged to JPY 92,009 MM, reflecting an impressive year-on-year growth rate of 89.45%. This substantial increase highlights the company's ability to enhance its profitability before tax considerations.</p>\n\n<p>The net profit for the quarter also demonstrated remarkable growth, ..."
      }
    ],
    "total": 3,
    "sid": "1130126",
    "stock_news_url": "https://www.marketsmojo.com/news/astellas-pharma-inc-1130126"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Astellas Pharma, Inc. Shows Strong Financial Growth Amidst Flat Performance

2025-11-11 16:16:05

Astellas Pharma, Inc. has reported its financial results for the quarter ending June 2025, revealing a mixed performance characterized by notable growth in key profit metrics despite an overall flat financial performance. The company's operating profit reached an impressive JPY 157,307 MM, marking the highest level recorded, with an operating profit margin of 31.1%. This indicates a strong operational efficiency and profitability for the company during this period.

In addition to the robust operating profit, Astellas Pharma, Inc. also reported significant growth in its pre-tax profit, which surged to JPY 92,009 MM, reflecting an impressive year-on-year growth rate of 89.45%. This substantial increase highlights the company's ability to enhance its profitability before tax considerations.

The net profit for the quarter also demonstrated remarkable growth, ...

Read full news article

View All News